COVID-19 therapeutics (medication)

Early detection is key when it comes to being considered for COVID-19 medication. Treatment for mild COVID-19 is recommended within 5 to 7 days of symptom onset.

The Report and Support online screening form assesses a person’s risk for serious illness due to COVID-19, and their eligibility for medications that could reduce the risk of hospitalization. It is important that you fill out the form as soon as you book your PCR test or get a positive rapid test result.

Anyone who is booking a PCR test or has tested positive on a rapid test should complete the form.

To complete the Report and Support screening form visit If you do not have access to the internet, please call 1-833-797-7772.

My symptoms are mild, should I take a COVID test?

In Nova Scotia, we encourage testing within 48 hours of noticing mild symptoms of COVID-19, such as sore throat, runny nose/nasal congestion, shortness of breath, cough, headache, fever (chills/sweats), nausea, vomiting or diarrhea. To book a PCR test visit


When should I complete the Report and Support online screening tool?

You should fill out the Report and Support online screening form when you book a PCR test, waiting for your PCR results or have received a positive result on your rapid test.

How do I complete the Report and Support form?

Complete the form online at If you are booking a PCR test by phone through 811, they will complete it for you. If you test positive on a rapid test and do not have access to the internet, you can call 1-833-797-7772 and a staff member will complete the form on your behalf.

Who will the information be shared with?

The information collected in this form will be shared with Public Health, the Infectious Diseases COVID-19 care team and the COVID-19 Community Virtual Care Team to support management and follow-up of priority cases.

If I fill out the form, does this guarantee that I get medication to treat COVID-19?

Medications for early and mild COVID are not appropriate for everyone, and people should be aware that filling out the screening form does not necessarily mean they need or should take medication. Duration and severity of symptoms, vaccination status, certain medical conditions and organ dysfunction, or some medications may deem therapy inappropriate.

Information from the form is also used to determine eligibility for other supports, such as from the COVID Community Virtual Care Team, or Public Health.

How will I know if I am eligible for medication/treatment?

This tool enables those who may be at risk and may benefit from medication/therapy to identify themselves. While not all people who complete this form will need a follow up phone call or treatment, those who do may receive a phone call from an unknown number, so please consider answering if you receive such a call.

If I complete the Report and Support online screening tool, what will happen to my information if I get a negative result?

If a person tests negative on a PCR test, their information will not be used, and will be deleted. If you have another PCR test in the future, you need to complete the web form again.

Can I wait until I get a positive PCR result to fill out the form?

Completing the form before a person’s PCR appointment and test result may seem premature, as the information will only be used if the person tests positive. However, there’s good reason for collecting the information early. Medications for early and mild COVID are recommended within 5 to 7 days of symptom onset. Providing information in the report and support form in advance will allow timely assessment for medication/treatment for those with a positive PCR result.

Can I get a prescription for medication from my family doctor/walk-in clinic/pharmacy?

An inhaler that contains budesonide (Pulmicort) may be appropriate for some patients with mild and early COVID. Any primary care provider can write a prescription for inhaled budesonide (Pulmicort).

A team of designated prescribers are responsible for writing prescriptions for remdesivir, sotrovimab, and nirmatrelvir/ritonavir (Paxlovid) that are also used for mild and early COVID in Nova Scotia. They cannot be initiated by prescribers who have not been identified as designated prescribers. The report and support tool screening tool is the way that these designated prescribers can determine if a person is eligible for medication.